Psoriasis Severity in HIV Associated With Low CD4 T-Cell Count
The characteristics of a general psoriasis populations were compared with that of those patients with psoriasis living with HIV.
Psoriasis
IL-17 vs TNF Inhibitors for New Biologic Agent Users With Psoriatic Disease
The long-term persistence of various biologic agents in treating psoriasis and psoriatic arthritis are investigated.
Inflammatory Skin Diseases Classified at Molecular Level
In research published online April 15 in Science Immunology, distinct classes of human inflammatory skin disease are defined at the molecular level.
Apremilast for Plaque Psoriasis of the Body and Scalp
A review regarding the safety, efficacy, and use of apremilast in treating patients with moderate to severe plaque psoriasis of the body and scalp, nail psoriasis, and palmoplantar psoriasis in adults is provided.
Cardiac Troponin I Level Linked to Atherosclerosis in Psoriatic Disease
Investigators sought to determine whether cTnI and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) were associated with carotid plaque burden and CV events independent of the Framingham Risk Score (FRS).
Biologic Agents, Dose Tapering, and Psoriasis
Predictors for successful dose reduction of adalimumab, etanercept, and ustekinumab for the treatment of psoriasis are assessed.
The Most Effective Biologic Agents in the Treatment of Psoriasis
Cumulative clinical benefits of psoriasis treatment with biologic agents over 1 year are compared.
A Phase 3 Trial of Imsidolimab, a Monoclonal Antibody Therapy for Generalized Pustular Psoriasis
To evaluate the safety and efficacy of imsidolimab in generalized pustular psoriasis (GPP), the design of a phase 3, international, multicenter, randomized, double-blind, placebo-controlled trial called Gemini-1 (ANB019-301) is proposed.
Brodalumab Equally Effective in Treating Scalp, Nail Psoriasis in Men and Women
The efficacy of brodalumab by self-identified gender in patients with nail or scalp psoriasis is investigated.
Hidradenitis Suppurativa Associated With Higher Risk for Inflammatory Bowel Disease
The incidence of overall IBD, ulcerative colitis, and Crohn’s disease in patients with and without chronic inflammatory skin disease is compared.
- Loading...
Loading...
Next post in AAD 2022
Loading... 
Loading...